HUMAN MUTATION 21:551 (2003)

CORRIGENDUM

Germline TP53 Mutations and Li-Fraumeni Syndrome J.M. Varleyn Paterson Institute for Cancer Research, Christie NHS Trust, Manchester, UK

The author changes to the proof were inadvertently omitted in the original article. Most significantly, two references, Evans et al. and Lalloo et al., were not

properly updated. Please find the corrected references below. The publisher regrets this error.

REFERENCES Evans DGR, Birch JM, Thorncroft M, McGown G, Lalloo F, Varley JM. 2003. Low rate of TP53 germline mutations in breast/sarcoma families not fulfilling classical criteria for Li-Fraumeni syndrome. J Med Genet 39: 941-944. Lalloo F, Varley J, Ellis D, O’Dair L, Pharoah P, The Early Onset Breat Cancer Study Group, Evans DGR. 2003. Family history is predictive of pathogenic, high penetrance mutations in BRCA1, BRCA2 and TP53 in early-onset breast cancer. Lancet (in press).

n

Correspondence to: J.M. Varley, Paterson Institute for Cancer Research, Christie NHS Trust, Wilmslow Road, Manchester M20 4BX, UK. E-mail: [email protected] Grant sponsor: Cancer Research UK. DOI 10.1002/humu.10218 r2003 WILEY-LISS, INC.